Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
Krishan K PandeyInstitute for Molecular Virology, Saint Louis University Health Sciences Center, St Louis, MO, USAAbstract: Human immunodeficiency virus type 1 (HIV-1) integrase inhibitors belong to a novel class of antiretroviral drugs with high potency and better tolerability. Elvitegravir (EVG) i...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-05-01
|
| Series: | HIV/AIDS: Research and Palliative Care |
| Online Access: | http://www.dovepress.com/critical-appraisal-of-elvitegravir-in-the-treatment-of-hiv-1aids-a16863 |